Synthesis and in vitro Anticancer Activities of some Selenadiazole Derivatives
- 25 November 2010
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 343 (11-12) , 680-691
Abstract
A novel series of fourteen substituted selenadiazoles has been synthesized and the compounds tested for their in vitro antiproliferative and cytotoxic activities. The tests were carried out against leukemia (CCRF‐CEM), colon (HT‐29), lung (HTB‐54), and breast (MCF‐7) cancer cells. In order to assess the selectivity of the compounds under investigation the assays were also carried out on two non‐tumoral lines – one mammary (184B5) and one bronchial epithelium (BEAS‐2B) cell line. Assay‐based antiproliferative activity studies revealed that seven derivatives (2a, 2c, 2e, 2f, 2g, 3a, and 3b) exhibited good activity against MCF‐7 cells: for instance, 2c and 2f inhibited cell growth with nanomolar GI50 values. Compound 2f had a better antitumoral profile than vinorelbine and paclitaxel, two drugs that are used as first‐line treatments in advanced, recurrent, and/or metastatic cancer. In the other cell lines the compounds showed moderate activity or were inactive – with the exception of 2a, which was also found to have antiproliferative activity. Modulation of the cell cycle and apoptotic effects of active compounds were further evaluated in MCF‐7 cells. Of these, 6‐bromo[1,2,5]selenadiazolo[3,4‐b]pyridine (2a) was the most active, with an apoptogenic effect 3.9 times higher than that of camptothecin, which was used as a positive control. Compound 2a also provoked cell cycle arrest with a significant decrease in the G0/G1 phase cell population and an increase in S and G2/M cells, thus suggesting mitotic arrest prior to metaphase.Keywords
This publication has 43 references indexed in Scilit:
- Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generationThe International Journal of Biochemistry & Cell Biology, 2009
- Role of drug transporters and drug accumulation in the temporal acquisition of drug resistanceBMC Cancer, 2008
- Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cellsChemico-Biological Interactions, 2008
- Selenium containing Heterocycles: Part 1. Synthesis of Some New Substituted Pyrido[3′,2′:4,5]selenolo[3,2-d]pyrimidines and Related Fused Tetracyclic SystemsJournal of Chemical Research, 2007
- A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulationBritish Journal of Nutrition, 2007
- Comparative analysis of xanafide cytotoxicity in breast cancer cell linesBritish Journal of Cancer, 2007
- Selenomethionine Induced Transcriptional Programs in Human Prostate Cancer CellsJournal of Urology, 2007
- 4-Methyl-1,2,3-selenadiazole-5-carboxylic acid amides: Antitumor action and cytotoxic effect correlationEuropean Journal of Medicinal Chemistry, 2007
- The Central Role of Metal Coordination in Selenium Antioxidant ActivityInorganic Chemistry, 2005
- Inorganic Selenium Retards Progression of Experimental Hormone Refractory Prostate CancerJournal of Urology, 2004